ly 274614 has been researched along with dezocine in 2 studies
Studies (ly 274614) | Trials (ly 274614) | Recent Studies (post-2010) (ly 274614) | Studies (dezocine) | Trials (dezocine) | Recent Studies (post-2010) (dezocine) |
---|---|---|---|---|---|
96 | 0 | 15 | 142 | 56 | 85 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allen, RM; Dykstra, LA | 1 |
Dykstra, LA; Fischer, BD; Henry, FE; Miller, LL; Picker, MJ | 1 |
2 other study(ies) available for ly 274614 and dezocine
Article | Year |
---|---|
Attenuation of mu-opioid tolerance and cross-tolerance by the competitive N-methyl-D-aspartate receptor antagonist LY235959 is related to tolerance and cross-tolerance magnitude.
Topics: Animals; Bridged Bicyclo Compounds, Heterocyclic; Cycloparaffins; Dose-Response Relationship, Drug; Drug Tolerance; Etorphine; Excitatory Amino Acid Antagonists; Isoquinolines; Male; Morphine; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, mu; Tetrahydronaphthalenes | 2000 |
Increased efficacy of micro-opioid agonist-induced antinociception by metabotropic glutamate receptor antagonists in C57BL/6 mice: comparison with (-)-6-phosphonomethyl-deca-hydroisoquinoline-3-carboxylic acid (LY235959).
Topics: Analgesics, Opioid; Animals; Bridged Bicyclo Compounds, Heterocyclic; Buprenorphine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hot Temperature; Isoquinolines; Male; Mice; Mice, Inbred C57BL; Morphine; Narcotic Antagonists; Pain Measurement; Receptors, Metabotropic Glutamate; Receptors, Opioid, mu; Tetrahydronaphthalenes | 2008 |